Mutations such as the 32 bp deletion within the CCR5 gene generally result in non-functional receptors, reduce the secretion of tobacco-induced inflammatory mediators and can therefore be considered as a risk factor for pancreatic cancer [181]. This evidence concerns the gene CCR5 and pancreatic neoplasm.